angiotensin ii has been researched along with 10-nitro-9,12-octadecadienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Chen, CS; Chen, YE; Cole, MP; Deng, CX; Fan, Z; Feng, YH; Freeman, BA; Garcia-Barrio, MT; Hamblin, M; Schopfer, FJ; Villacorta, L; Zhang, J; Zhu, T | 1 |
| Ambrozova, G; Baldus, S; Freeman, BA; Friedrichs, K; Kaur, JJ; Klinke, A; Kubala, L; Martiskova, H; Matthes, B; Mollenhauer, M; Pekarova, M; Ravekes, T; Rudolph, TK; Rudolph, V; Schwoerer, A; Woodcock, SR | 1 |
2 other study(ies) available for angiotensin ii and 10-nitro-9,12-octadecadienoic acid
| Article | Year |
|---|---|
Nitro-oleic acid inhibits angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Hypertension; Linoleic Acids; Mice; Mice, Inbred C57BL; Nitro Compounds; Oleic Acid; Oleic Acids; Rats; Rats, Sprague-Dawley | 2010 |
Nitrated fatty acids suppress angiotensin II-mediated fibrotic remodelling and atrial fibrillation.
Topics: Action Potentials; Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Cell Transdifferentiation; Cells, Cultured; Connexin 43; Fibrosis; Heart Atria; Linoleic Acids; Mice; Mice, Inbred C57BL; Nitro Compounds; Smad2 Protein | 2016 |